tiprankstipranks
Parnell Pharmaceuticals (PARNF)
OTHER OTC:PARNF
US Market
Holding PARNF?
Track your performance easily

Parnell Pharmaceuticals (PARNF) Financial Statements

16 Followers

Parnell Pharmaceuticals Financial Overview

Parnell Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Parnell Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 16Sep 16Jun 16Dec 15Sep 15
Income Statement-
Total Revenue$ 6.42M$ 4.55M-$ 4.05M$ 6.17M
Gross Profit$ 3.78M$ 1.86M-$ 1.54M$ 4.08M
EBIT$ -1.74M$ -5.54M-$ -7.97M$ -1.85M
EBITDA$ -1.74M$ -5.54M-$ -7.97M$ -1.85M
Net Income Common Stockholders$ -3.11M$ -6.11M-$ -8.32M$ -2.43M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.12M$ 2.07M$ 4.10M$ 5.67M$ ―
Total Assets$ 47.58M$ 39.05M$ 46.66M$ 46.21M-
Total Debt$ 29.84M$ 16.94M$ 20.20M$ 17.48M$ ―
Net Debt$ 22.73M$ 14.87M$ 16.10M$ 11.81M$ ―
Total Liabilities$ 39.51M$ 26.88M$ 29.85M$ 25.95M-
Stockholders Equity$ 8.06M$ 12.17M$ 16.81M$ 20.25M$ ―
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Parnell Pharmaceuticals Earnings and Revenue History

Parnell Pharmaceuticals Debt to Assets

Parnell Pharmaceuticals Cash Flow

Parnell Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis